Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: Review of the literature;Les criteres de diagnostic clinique de la maladie de Parkinson et des syndromes parkinsoniens: Revue de la litterature

Revue Neurologique

Volumn 156, Issue SUPPL. 2 BIS, 2000, Pages 14-22

  Vercueil, L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; CORTICOBASAL DEGENERATION; HUMAN; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; RELIABILITY; SHY DRAGER SYNDROME;

HUMANS; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0033925818     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (72)

1. ALBANESE A, COLOSIMO C, BENTIVOGLIO AR, FENICI R, MELILLO G, COLOSIMO C, TONALI P. (1995). Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry, 59: 144-151.
2. BERGERON CB, POLLANEN MS, WEYER L, BLACK SE, LANG AE. (1996). Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol, 40: 72-79.
3. BLIN J, BARON JC, DUBOIS B et al. (1990). Positron emission tomography study in progressive supranuclear palsy: brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol, 47: 747-752.
4. BOEVE BF, Maraganore DM, Parisi JE et al. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53: 795-800.
5. BYRNE EJ, LENNOX G, LOWE J et al. (Nottingham Group for the study of neurodegenerative disorders). (1991). Diagnostc criteria for dementia associated with cortical Lewy bodies. Dementia, 2: 283-284.
6. CALNE DB, SNOW BJ, LEE C. (1992). Criteria for diagnosing Parkinson's disease. Ann Neurol, 32 (Suppl): S125-127.
7. CAPARROS-LEFEBVRE D, LEES A, on the behalf of the Caribbean Parkinsonism Study Group. (1999). Atypical parkinsonism in the French West Indies. Author's reply. Lancet, 354: 1473.
8. COHEN J, LOW P, FEALEY R, SHEPS SG, JIANG N-S. (1987). Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol, 22: 692-699.
9. COLOSIMO C, ALBANESE A, HUGHES AJ, DE BRUIN VMS, LEES AJ. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol, 52: 294-298.
10. COLLINS SJ, ASHROG JE, PARISI JE, MARAGANORE DM. (1995). Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry, 58: 167-173.
11. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. (1996). Clin Auton, Res 6: 125-126.
12. DANIEL SE, DE BRUIN VMS, LEES AJ. (1995). The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain, 118: 759-770.
13. DAVIS PH, BERGERON C, MCLACHLAN DR. (1985). Atypical presentations of progressive supranuclear palsy. Ann Neurol, 17: 337-343.
14. DE RUK MC, ROCCA WA, ANDERSON DW, MELCOM MO, BRETELER MM, MARAGANORE DM. (1997). A population perspective on diagnostic criteria for Parkinson's disease. Neurology, 48: 1277-1281.
15. FORNO LS. (1966). Pathology of parkinsonism. A preliminary report of 24 cases. J Neurosurg, 24: 266-271.
16. GELB DJ, OLIVER E, GILMAN S. (1999). Diagnostic criteria for Parkinson's disease. Arch Neurol, 56: 33-39.
17. GIBB WRG. (1988a). Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J, 64: 345-351.
18. GIBB WRG, LEES AJ. (1988b). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry, 51: 745-752.
19. GILMAN S, LOW P, QUINN N et al. (1999). Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci, 163: 94-98
20. GILMAN S, LOW P, QUINN N et al. (1998). Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res, 8: 359-362.
21. GNANALINGHAM KK, BYRNE EJ, THORNTON A, SANBROOK MA, BANNISTER P. (1997). Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry, 62: 243-252.
22. GOETZ CG, LITVAN I, STEBBINGS GT et al. (1996). The accuracy of clinical signs in sperating autopsy-proven corticobasal ganglionic degeneration from Parkinson's disease: positive and negative predictive value analysis. (Abstract) Neurology, 469 (Suppl): A260-261.
23. GOLBE LI, DAVIS PH, SCHOENBERG BS and DUVOISIN RC. (1988). Prevalence and natural history of progressive supranuclear palsy. Neurology, 38: 1031-1034.
24. GOUIDER-KHOUJA N, VIDAILHET M, BONNET A-M, PICHON J, AGID Y. (1995). "Pure" striatonigral degeneration and Parkinson's disease: A comparative clinical study. Mov Disord, 10: 288-294.
25. GRAHAM JG, OPPENHEIMER DR. (1969). Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry, 32: 28-34.
26. GRIMES DA, LANG AE, BERGERON CB. (1999). Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology, 53: 1969-1974.
27. HOLMES C, CAIRNS N, LANTOS P, MANN A. (1999). Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry, 174: 45-51.
28. HUGHES AJ, LEES AJ, STERN GM. (1991). Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 41: 1723-1725.
29. HUGHES AJ, DANIEL SE, KILFORD L, LEES AJ. (1992a). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 55: 181-184.
30. HUGHES AJ, BEN-SHLOMO Y, DANIEL SE, LEES AJ. (1992b). What feature improve the accuracy of clinical diagnosis in Parkinson's disease. Neurology, 42: 1142-1146.
31. HUGHES AJ, DANIEL SE, BLANKSON S, LEES AJ. (1993). A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol, 50: 140-148.
32. JACKSON JA, JANKOVIC J, FORD J. (1983). Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol, 13: 273-278.
33. KOLLER WC. (1992). How accurately can Parkinson's disease be diagnosed? Neurology, 42 (Suppl.1): 6-16.
34. KOLLER WC, MONTGOMERY EB. (1997). Issues in the early diagnosis of Parkinson's disease. Neurology, 49 (Suppl1): S10-25.
35. KOMPOLITI K, GOETZ CG, BOEVE BF et al. (1998). Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol, 55: 957-961.
36. rd. Ed Baltimore: Williams & Wilkins: 297-316.
37. LANG AE, RILEY DE, BERGERON C. (1994). Cortico-basal ganglionic degeneration. In: Calne DB , ed. Neurodegenerative diseases. Philadelphia. WB Saunders: 877-894.
38. LANGSTON JW, WIDNER H, GOETZ CG, BROOKS D, FAHNS S, FREEMAN T, WATTS R. (1992). Core assessment program for intracerebral transplantations (CAPIT). Mov Disord, 7: 2-13
39. LARSEN JP, DUPONT E, TANDBERG E. (1994). Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand, 89: 242-251.
40. LEES AJ. (1987). The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy. In Movement Disorders 2. Eds Marsden CD and Fahs S. London, Butterworth: 272-287.
41. LITVAN I, AGID Y, CALNE D et al. (1996a). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology, 46: 922-930.
42. LITVAN I, AGID Y, GOETZ C. (1996b). Validity of clinical diagnosis of corticobasal ganglionic degeneration. (Abstract) Mov Disord, 11: 354-355
43. LITVAN I, AGID Y, CALNE D et al. (1996c). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47:1-9
44. LITVAN I, GOETZ GC, JANKOVIC J et al. (1997). What is the accuracy of the clinical diagnosis of Multiple System Atrophy? A clinicopathologic study. Arch Neurol, 54: 937-944.
45. LITVAN I, MACINTYRE A, GOETZ CG, et al. (1998). Accuracy of the clinical diagnoses of Lewy Body disease, Parkinson disease, and Dementia with Lewy Bodies. A Clinicopathologic study. Arch Neurol, 55: 969-978.
46. LOUIS ED, KLATKA LA, LIU Y, FAHN S. (1997). Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology, 48: 376-380.
47. MCKEITH IG, PERRY RH, FAIRBAIRN AF, JABEEN S, PERRY EK. (1992). Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med, 22: 911-22.
48. MCKEITH IG, FAIRBAIRN AF, PERRY RH, THOMPSON P. (1994). The clinical diagnosis and misdiagnostis of senile dementia of Lewy body type (SDLT). Br J Psychiatry, 165: 324-332.
49. MCKEITH IG GALASKO D, KOSAKA K, et al.. (1996). Consensus guideline for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Report of the consortium on DLB international workshop. Neurology, 47: 1113-1124
50. MCKEITH IG, PERRY EK, PERRY RH. (1999). Report of the second dementia with Lewy body international workshop. Diagnosis and treatment. Neurology, 53: 902-905.
51. MARTTILA RJ, RINNE UK. (1976). Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand, 53: 81-102.
52. MEGA MS, MASTERMAN DL, BENSON F, et al. (1996). Dementia with Lewy bodies: reliability and validity ot clinical and pathologic criteria. Neurology, 47: 1403-1409.
53. MORRIS HR, WOOD NW, LEES AJ. (1999). Progressive supranuclear palsy (Steele-Richardson-Olszewski disease). Postgrad Med J, 75: 579-584
54. QUINN N. (1989). Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry, Suppl.: 78-89
55. QUINN N. (1994). Multiple system atrophy. In Movement Disorders 3. Eds Marsden CD and Fahs S. London, Butterworth: 262-281.
56. RAJPUT AH, ROZDILSKY B, RAJPUT A. (1991). Accuracy of clinical diagnosis in parkinsonism. A prospective study. Can J Neurol Sci, 18: 275-278
57. REIBETZ JJ, KOLODNY EH, RICHARDSON EP. (1968). Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol, 18: 20-33.
58. RILEY DE, LANG AE, LEWIS A et al. (1990). Corticobasal ganglionic degeneration. Neurology, 40: 1203-1212.
59. RILEY DE, LANG AE. (2000). Clinical diagnostic criteria. Adv Neurol, 82: 29-34.
60. SCARAVILLI T, PRAMSTALLER PP, SALERNO , GIOMETTO B, REVESZ T. (2000). Involvement of the onuf nucleus in progressive supranuclear palsy. Neurology, 54 (Suppl 3): A392.
61. SCHNEIDER JA, WATTS RL, GEARING M, BREWER RP, MIRRA SS. (1997). Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology, 48: 959-969.
62. STEELE JC, RICHARDSON JC and OLSZEWSKI J. (1964). A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudo-bulbar palsy, nuchal dystonia and dementia. Arch Neurol, 10: 333-358.
63. TOLOSA E, VALLDERIOLA F and MARTI MJ. (1994). Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm, 42 (suppl.): 15-32.
64. TOLOSA E, VALLDEORIOLA F, CRUZ-SANCHEZ F. (1995). Progressive supranuclear palsy: clinical and pathological diagnosis. Eur J Neurol, 2: 259-273.
65. VALLDERIOLA F, TOLOSA E, VALLS-SOLÉ J. (1996). Differential diagnosis and clinical diagnostic: criteria of Progressive supranuclear palsy. Adv Neurol, 69: 405-412.
66. VERGHESE J, CRYSTAL HA, DICKSON DW, LIPTON RB. (1999). Validity of clinical criteria for the diagnosis of dementia with Lewy body. Neurology, 53: 1974-1982.
67. VIDAILHET M, BONNET A-M, AGID Y. (1998). Critères cliniques de diagnostic des atrophies multisystématisées. Rev Neurol, 154 : 17-21.
68. WARD CD, GIBB WR. (1990). Research diagnostic criteria for Parkinson's disease. Adv Neurol, 53: 245-249.
69. WENNING GK, BEN SHLOMO Y, MAGALHAES M, DANIEL SE, QUINN NP. (1994). Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain, 117: 835-845.
70. WENNING GK, BEN-SHLOMO Y, MAGALHAES M, DANIEL SE, QUINN NP. (1995). Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry, 58: 160-166
71. WENNING GK, TISON F, BEN-SHLOMO Y et al. (1997). Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord, 12: 133-147.
72. WENNING GK, LITVAN I, JANKOVIC J et al. (1998). Natural history and survival of 14 patients with Corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry, 64: 184-189.